Shares plunge on AI fears: Social media buzz intensified after IBM's stock tumbled 13% in a day, wiping out substantial market value amid fears that Anthropic's Claude AI could automate COBOL code modernization. Traders highlighted the threat to IBM's lucrative mainframe services, long protected by a scarcity of legacy expertise. The reaction painted a stark picture of AI's potential to upend established tech moats overnight.
Analysts counter the sell-off: Amid the downturn, discussions amplified Evercore's reiterated outperform rating and $345 price target, labeling the drop as unwarranted overreaction. Posters noted that complex migrations still demand IBM's audited safeguards and uptime assurances. This pushback fueled debates on whether mainframe fears are overblown despite AI advances.
Cautious sentiment prevails: Conversations extended to IBM's AI hiring push and quantum leadership as potential offsets, yet broader AI trade reversals loomed large. Some likened the episode to structural shifts hitting other tech incumbents. Overall, the tone remains predominantly bearish, with eyes on upcoming catalysts to test resilience.
Note: This discussion summary was generated from an AI condensation of post data.
IBM Insider Trading Activity
IBM insiders have traded $IBM stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IBM stock by insiders over the last 6 months:
- DAVID N FARR purchased 1,000 shares for an estimated $304,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IBM Revenue
IBM had revenues of $19.7B in Q4 2025. This is an increase of 12.15% from the same period in the prior year.
You can track IBM financials on Quiver Quantitative's IBM stock page.
IBM Congressional Stock Trading
Members of Congress have traded $IBM stock 9 times in the past 6 months. Of those trades, 6 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $IBM stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 2 purchases worth up to $65,000 on 01/08 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 12/19, 11/12 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE LLOYD DOGGETT purchased up to $15,000 on 12/12.
- SENATOR SHELLEY MOORE CAPITO sold up to $50,000 on 10/29.
- REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 10/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
IBM Hedge Fund Activity
We have seen 1,668 institutional investors add shares of IBM stock to their portfolio, and 1,528 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 19,784,058 shares (-73.1%) from their portfolio in Q4 2025, for an estimated $5,860,235,820
- CAPITAL WORLD INVESTORS added 4,976,756 shares (+29.2%) to their portfolio in Q4 2025, for an estimated $1,474,164,894
- GQG PARTNERS LLC removed 4,692,192 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,323,948,894
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,553,552 shares (+83.4%) to their portfolio in Q4 2025, for an estimated $756,387,637
- PITCAIRN CO removed 1,674,105 shares (-99.8%) from their portfolio in Q3 2025, for an estimated $472,365,466
- JPMORGAN CHASE & CO removed 1,548,522 shares (-9.2%) from their portfolio in Q4 2025, for an estimated $458,687,701
- CORIENT PRIVATE WEALTH LLC added 1,484,026 shares (+359.6%) to their portfolio in Q4 2025, for an estimated $439,583,341
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IBM Government Contracts
We have seen $1,138,750,700 of award payments to $IBM over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BENEFITS TRANSFORMATION PLATFORM: $132,052,045
- NAVY ENTERPRISE RESOURCE PLANNING (ERP) TECHNICAL SUPPORT SERVICES (NETSS).: $124,828,089
- ORDER FOR Z17 CLINS OFF THE IBM CONTRACT: $77,398,572
- SUSTAINMENT, ENHANCEMENT AND TRANSITION SUPPORT OF VAS ENTERPRISE CORE HR SOLUTION - HRSMART. THE CONTRACT...: $74,437,373
- CDS BRIDGE CONTRACT POP 09/08/2023 - 09/07/2025: $63,780,665
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
IBM Analyst Ratings
Wall Street analysts have issued reports on $IBM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/29/2026
- UBS issued a "Sell" rating on 01/29/2026
- Evercore ISI Group issued a "Outperform" rating on 01/20/2026
- RBC Capital issued a "Outperform" rating on 01/05/2026
- Stifel issued a "Buy" rating on 12/09/2025
- Oppenheimer issued a "Outperform" rating on 11/21/2025
- B of A Securities issued a "Buy" rating on 10/23/2025
To track analyst ratings and price targets for IBM, check out Quiver Quantitative's $IBM forecast page.
IBM Price Targets
Multiple analysts have issued price targets for $IBM recently. We have seen 12 analysts offer price targets for $IBM in the last 6 months, with a median target of $337.5.
Here are some recent targets:
- Dan Ives from Wedbush set a target price of $340.0 on 01/29/2026
- Brent Thill from Jefferies set a target price of $370.0 on 01/29/2026
- David Vogt from UBS set a target price of $236.0 on 01/29/2026
- Brian Essex from JP Morgan set a target price of $317.0 on 01/29/2026
- David Grossman from Stifel set a target price of $340.0 on 01/29/2026
- Matthew Swanson from RBC Capital set a target price of $361.0 on 01/29/2026
- Amit Daryanani from Evercore ISI Group set a target price of $345.0 on 01/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
